| RS2482687881 |
CFB
|
Health Risk |
Likely pathogenic |
Complement factor b deficiency, Complement factor b deficiency |
| RS2482690290 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482690458 |
ZAP70
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to ZAP70 deficiency, Combined immunodeficiency due to ZAP70 deficiency |
| RS2482690509 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482690703 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482690956 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482708060 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482709868 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482725233 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482725469 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482725528 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482726726 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482727350 |
TNFAIP3
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, familial |
| RS2482729637 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482733805 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482735559 |
HIVEP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2482735643 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482736603 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482736672 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482737064 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482737363 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482741381 |
ZAP70
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to ZAP70 deficiency, Combined immunodeficiency due to ZAP70 deficiency |
| RS2482743566 |
TNFAIP3
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS2482749858 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482750192 |
TNFAIP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autoinflammatory syndrome, familial |
| RS2482752267 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482753368 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482756016 |
ZAP70
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to ZAP70 deficiency, Combined immunodeficiency due to ZAP70 deficiency |
| RS2482757985 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482759087 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482764108 |
GABBR1
|
Health Risk |
Likely pathogenic |
Delayed speech and language development, Intellectual disability |
| RS2482766787 |
ZAP70
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to ZAP70 deficiency, Combined immunodeficiency due to ZAP70 deficiency |
| RS2482767087 |
LAMA2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Merosin deficient congenital muscular dystrophy |
| RS2482767348 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482767452 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482772444 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS2482772626 |
HIVEP2
|
Health Risk |
Pathogenic |
— |
| RS2482772851 |
HIVEP2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2482774022 |
HIVEP2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2482775510 |
MICAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial temporal lobe |
| RS2482776118 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482776142 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482776159 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482776338 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482776429 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482776474 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482776508 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2482776881 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2482776932 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482777785 |
LAMA2
|
Health Risk |
Likely pathogenic |
— |
| RS2482777806 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2482777827 |
LAMA2
|
Health Risk |
Likely pathogenic |
— |
| RS2482794327 |
ASCC3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 81 |
| RS2482796579 |
HIVEP2
|
Health Risk |
Likely pathogenic |
HIVEP2-related disorder, HIVEP2-related disorder |
| RS2482798077 |
MED23
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2482809051 |
ASCC3
|
Health Risk |
Likely pathogenic |
ASCC3-related disorder, ASCC3-related disorder |
| RS2482810069 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2482810190 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2482811651 |
HIVEP2
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2482814588 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2482819366 |
HIVEP2
|
Health Risk |
Pathogenic |
— |
| RS2482820753 |
HIVEP2
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2482822001 |
HIVEP2
|
Health Risk |
Pathogenic |
— |
| RS2482829253 |
HIVEP2
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2482830872 |
HIVEP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2482835520 |
HIVEP2
|
Health Risk |
Pathogenic |
— |
| RS2482835597 |
HIVEP2
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2482839679 |
HIVEP2
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2482848939 |
SLC35A1
|
Health Risk |
Pathogenic |
SLC35A1-congenital disorder of glycosylation, SLC35A1-congenital disorder of glycosylation |
| RS2482849173 |
HIVEP2
|
Health Risk |
Pathogenic |
— |
| RS2482852662 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482856946 |
HIVEP2
|
Health Risk |
Pathogenic |
— |
| RS2482857854 |
HIVEP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 43 |
| RS2482859580 |
HIVEP2
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS2482863935 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482868678 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482870790 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482870919 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482871841 |
ZBTB24
|
Health Risk |
Likely pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482872102 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482872147 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482876788 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482879619 |
ZBTB24
|
Health Risk |
Likely pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482880722 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482880840 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482880948 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482881066 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482881376 |
ZBTB24
|
Health Risk |
Likely pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482881880 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482881977 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482882524 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482882627 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482882661 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482882746 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482883121 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482883789 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS2482887587 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482889698 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482889886 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS2482891698 |
POLR1C
|
Health Risk |
Likely pathogenic |
POLR1C-related disorder, POLR1C-related disorder |